Logo Boehringer Ingelheim

Boehringer-Ingelheim Logo
  • Home|
  • Contact|
  • Site Map
Submit

Value through Innovation

6 January 2009
  • News Centre
    • News Releases
    • Press Conferences
    • Conference Calendar
    • Annual Report
    • Media Material
      • Information Packs
      • Images & Videos
      • Publication Download
      • Glossaries
      • FAQs
      • Interesting Links
    • Journalists' Awards
    • Media Contacts
  • Clinical Trials
  • Corporate Profile
  • Global Activities
  • Careers
  • Research & Development
  • Products
  • Industrial Customers

Information Packs

  • Home
  • News Centre
  • Media Material
  • Information Packs
  • Major Depressive Disorder (MDD)

Background information for Journalists

Journalist's Information Pack
Major Depressive Disorder (MDD) Background information for medical media outside the US only This selection gives an overview on background material for Major Depressive Disorder (MDD) available on the Boehringer Ingelheim corporate website.

Press Releases

  • 16 October 2007New data suggests doctors might not be considering depression symptoms that are important to patients, such as pain and anxiety
  • 23 May 2007Workplace burden of depression magnified by co-morbid fatigue and anxiety, new study shows
  • 23 May 2007In new study, Duloxetine was equally effective, regardless of switch method, in reducing painful symptoms in SSRI non- or partial-responders with depression
  • press release archive

Documents

  • Annual Report 2007: Page 51 - PDF (4.9 MB)

Related Links

  • APOPIS awards
  • Focus on Clincal Research - interactive animation
  • License agreements
  • Research & Development

External Links

  • Boehringer Ingelheim Global Clinical Trials website
back to overview - Information Packs
back to top
© 1999 - 2009
Boehringer Ingelheim GmbH
All rights reserved
  • Recommend
  • |Print Page
  • |Imprint
  • |Terms of use
  • |RSS Feed
Last update: 02.07.2008